AIM

AIM ImmunoTech
AIM

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $578K invested in AIM ImmunoTech in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$301K
2
+$110K
3
+$94.6K
4
Bank of America
Bank of America
North Carolina
+$8K
5
ARTA
A.R.T. Advisors
New York
+$1.74K

Top Sellers

1
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$301K
2
$141K
3
$110K
4
$9K
5
$8K
6
$8K
7
$393
8
$174
9
–